We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

162 hedge funds and large institutions have $589M invested in Natus Medical Inc in 2013 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

154% more call options, than puts

Call options by funds: $6.84M | Put options by funds: $2.69M

59% more capital invested

Capital invested by funds: $372M → $589M (+$218M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

22% more funds holding

Funds holding: 133162 (+29)

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

Holders
162
Holders Change
+29
Holders Change %
+21.8%
% of All Funds
4.7%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
40
Increased
57
Reduced
51
Closed
10
Calls
$6.84M
Puts
$2.69M
Net Calls
+$4.15M
Net Calls Change
+$4.65M
Name Holding Trade Value Shares
Change
Change in
Stake
DII
126
Domini Impact Investments
New York
$263K +$229K +11,845 New
Verition Fund Management
127
Verition Fund Management
Connecticut
$245K +$210K +10,870 New
Citigroup
128
Citigroup
New York
$234K +$153K +7,912 +319%
ACM
129
Alta Capital Management
Utah
$229K +$197K +10,190 New
Thrivent Financial for Lutherans
130
Thrivent Financial for Lutherans
Minnesota
$227K
Cambridge Investment Research Advisors
131
Cambridge Investment Research Advisors
Iowa
$224K +$192K +9,950 New
PA
132
Profund Advisors
Maryland
$217K -$38.1K -1,975 -17%
Wells Fargo
133
Wells Fargo
California
$211K -$39.6K -2,050 -18%
Loomis, Sayles & Company
134
Loomis, Sayles & Company
Massachusetts
$206K +$177K +9,170 New
PI
135
PineBridge Investments
New York
$167K +$82.1K +4,249 +134%
PG
136
PEAK6 Group
Illinois
$160K -$482K -24,943 -78%
TRSOTSOK
137
Teachers Retirement System of the State of Kentucky
Kentucky
$149K
OA
138
OFI Advisors
Pennsylvania
$148K -$24.4K -1,261 -16%
KBC Group
139
KBC Group
Belgium
$137K +$118K +6,087 New
MSA
140
Mason Street Advisors
Wisconsin
$100K +$7.05K +365 +9%
HR
141
Howe & Rusling
New York
$84K +$9.66K +500 +16%
Royal Bank of Canada
142
Royal Bank of Canada
Ontario, Canada
$78K -$425K -22,010 -86%
Federated Hermes
143
Federated Hermes
Pennsylvania
$70K +$60.2K +3,119 New
Public Employees Retirement Association of Colorado
144
Public Employees Retirement Association of Colorado
Colorado
$65K
Barclays
145
Barclays
United Kingdom
$61K -$215K -11,122 -80%
Canada Life
146
Canada Life
Manitoba, Canada
$49K +$42.1K +2,181 New
TRCT
147
Tower Research Capital (TRC)
New York
$47K +$30.6K +1,584 +309%
HNB
148
Huntington National Bank
Ohio
$37K -$15.8K -816 -33%
HMS
149
Hanseatic Management Services
New Mexico
$31K +$26.9K +1,391 New
BlackRock
150
BlackRock
New York
$27K

NTUS Hedge Fund Activity: Q4 2013 in Review

162 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2013, worth a combined $589M — up 59% from $372M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NTUS positions and 10 closed out — a net gain of 30 holders — while 57 added to existing stakes and 51 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $7.33M. The largest seller was Broadfin Capital, cutting an estimated $29.1M.

  • 162 institutional investors held Natus Medical Inc (NTUS) as of Q4 2013, up from 133 in Q3 2013.
  • Funds reported $589M of Natus Medical Inc stock for Q4 2013, up 59% quarter-over-quarter.
  • 40 funds opened new Natus Medical Inc positions in Q4 2013 and 10 closed out, a net change of +30 holders.
  • The largest Natus Medical Inc buyer in Q4 2013 was Eagle Asset Management, an estimated $7.33M added.
  • The largest Natus Medical Inc seller in Q4 2013 was Broadfin Capital, an estimated $29.1M sold.

Based on aggregated 13F filings for Q4 2013.